Literature DB >> 26131032

Management of Aortic Replacement-Induced Chylothorax by Lipiodol Lymphography.

Hiroto Kitahara1, Akihiro Yoshitake1, Takashi Hachiya1, Yu Inaba1, Kentaro Tamura2, Hideki Yashiro2, Seiji Nakatsuka2, Hideyuki Shimizu1.   

Abstract

Chylothorax is a rare but serious complication of thoracic aortic surgery, leading to malnutrition, respiratory insufficiency, and prolonged hospital stay. In this article, we describe the successful treatment of a case of intractable chylothorax by lipiodol lymphography. The patient was a 39-year-old man who underwent descending aortic replacement for a remaining dissected aneurysm after total arch replacement. Chylothorax developed postoperatively. After complete oral intake cessation, total parenteral nutrition, and plasmatic factor XIII administration, lipiodol lymphography detected the chyle leakage location and subsequently decreased pleural effusion. The patient recovered uneventfully and was discharged on postoperative day 30 without any complications.

Entities:  

Keywords:  aortic surgery complication; chylothorax; lipiodol lymphography

Year:  2015        PMID: 26131032      PMCID: PMC4485038          DOI: 10.3400/avd.cr.15-00002

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  8 in total

1.  Current management of postoperative chylothorax.

Authors:  H Fahimi; F P Casselman; M A Mariani; W J van Boven; P J Knaepen; H A van Swieten
Journal:  Ann Thorac Surg       Date:  2001-02       Impact factor: 4.330

2.  Chylothorax complicating repairs of the descending and thoracoabdominal aorta.

Authors:  Adnan H Allaham; Anthony L Estrera; Charles C Miller; Paul Achouh; Hazim J Safi
Journal:  Chest       Date:  2006-10       Impact factor: 9.410

3.  Effectiveness of therapeutic lymphography on lymphatic leakage.

Authors:  Enrique Alejandre-Lafont; Christoph Krompiec; Wigbert S Rau; Gabriele A Krombach
Journal:  Acta Radiol       Date:  2011-04-01       Impact factor: 1.990

4.  Thoracic duct embolization for chylous leaks.

Authors:  Eric Chen; Maxim Itkin
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

5.  Plasmatic [corrected] factor XIII reduces severe pleural effusion in children after open-heart surgery.

Authors:  M Schroth; U Meißner; R Cesnjevar; M Weyand; H Singer; W Rascher; J Klinge
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

6.  VATS thoracic-duct division for aortic surgery-related chylous leakage.

Authors:  Toshiya Ohtsuka; Mikio Ninomiya; Jotaroh Kobayashi; Yukihiro Kaneko
Journal:  Eur J Cardiothorac Surg       Date:  2005-01       Impact factor: 4.191

7.  The effectiveness of lymphangiography as a treatment method for various chyle leakages.

Authors:  T Matsumoto; T Yamagami; T Kato; T Hirota; R Yoshimatsu; T Masunami; T Nishimura
Journal:  Br J Radiol       Date:  2008-11-24       Impact factor: 3.039

8.  Administration of octreotide for management of postoperative high-flow chylothorax.

Authors:  Fabio Barili; Gianluca Polvani; Veli K Topkara; Luca Dainese; Maurizio Roberto; Emad Aljaber; Massimo Bettoni; Faisal H Cheema; Piero Trabattuni; Alessandro Parolapi; Rita Spirito; Paolo Biglioli
Journal:  Ann Vasc Surg       Date:  2007-01       Impact factor: 1.466

  8 in total
  3 in total

1.  Chylous Ascites after Abdominal Aortic Aneurysm Repair.

Authors:  Shinichi Ohki; Soki Kurumisawa; Yoshio Misawa
Journal:  Ann Vasc Dis       Date:  2015-12-03

2.  Lymphangiography and subsequent sclerotherapy can be easily applied by cannulation of the lymph duct with a catheter for the neonatal central vein.

Authors:  Tomomi Kimura; Kenjiro Hasegawa; Sunao Morisada; Kiichi Inagawa; Kouhei Tsukahara; Takaaki Ensako; Shogo Ebisudani; Fumiaki Nagashima; Ikuko Osugi; Masaharu Ishikawa; Takashi Harada; Miori Teramoto; Masateru Inai
Journal:  Clin Case Rep       Date:  2017-03-08

3.  Lymphatic imaging and intervention for chylothorax following thoracic aortic surgery.

Authors:  Cheng Shi Chen; Jong Woo Kim; Ji Hoon Shin; Hyun Jung Koo; Joon Bum Kim; Hai-Liang Li; Se Hwan Kwon; Alrashidi Ibrahim; Almoaiad A Alhazemi; Hee Ho Chu
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.